GSK pulls Tyverb extension in Europe
February 17, 2012Sales and Marketing GSK, Herceptin, Tyverb, Xeloda
GlaxoSmithKline has withdrawn its European application to extend the licence of its breast cancer pill Tyverb. The firm was seeking …
UCB releases ‘Epilepsy In Our Time’ video diaries
February 17, 2012Medical Communications UCB, epilepsy
UCB has released Epilepsy In Our Time, a video diary that explores life with epilepsy from the perspective of those …
Life tops up its team with two new appointments
February 17, 2012Medical Communications Life healthcare communications
Life Healthcare Communications has made two new appointments, growing its client service and production departments. Matt Leeming joins Life as …
NICE no for first line Tarceva
February 17, 2012Sales and Marketing CDF, Cancer, NICE, Roche, Tarceva
NICE no for first line Tarceva Watchdog wants more information on Roche’s drug NICE is not recommending Roche’s lung cancer …
Merck unveils Brazilian joint venture
February 17, 2012Sales and Marketing Brazil, Merck & Co, Supera Farma, emerging markets
Merck Inc has bolstered its presence in emerging markets by entering a joint venture with Brazilian firm Supera Farma Laboratorios. Due …
Cimzia results excite UCB in psoriatic arthritis
February 16, 2012Research and Development, Sales and Marketing Cimzia, UCB, psoriatic arthritis
UCB will submit Cimzia for psoriatic arthritis by the end of 2012, after positive Phase III trial results for the …
Words – the most powerful drug
February 16, 2012Medical Communications
Why good internal communication within organisations is essential in these fraught timesBy William Hind, Founder – AlpharmaximThe precise quote by …
Panu Miettinen appointed chief financial officer of Biotie
February 16, 2012Business Services, Research and Development, Sales and Marketing Biotie, Panu Miettinen
Panu Miettinen, 43, has been appointed chief financial officer of Biotie Therapies. He will become a member of the Group’s …
EMA appoints new head of information and communications technology
February 16, 2012Business Services, Medical Communications, Sales and Marketing EMA, Luc Verhelst
Luc Verhelst has been appointed as the new head of the European Medicines Agency’s information and communications technology unit. Verhelst …
MRN launches online training portal
February 16, 2012Research and Development
16 February 2012 – Medical Research Network (MRN), the unique Clinical Trial Support Organisation (CTSO) offering home trial support, site …
NICE frowns on Botox for headache prevention
February 16, 2012Sales and Marketing Allergan, Botox, EMA, NHS, NICE
NICE is not recommending Allergan’s Botox for headache prevention, and has asked the firm for more information on the drug. …
Amgen appoints Michael Severino as senior vice president, Global Development and Corporate chief medical officer
February 16, 2012Business Services, Research and Development, Sales and Marketing
Michael Severino has been named senior vice president, Global Development and Corporate chief medical officer at Amgen.Severino, 46, formerly vice president, …
Teva launches generic Aricept in the UK
February 16, 2012Manufacturing and Production, Sales and Marketing Alzheimer's, Aricept, NHS, Pfizer, Teva
Teva has launched its generic version of Alzheimer’s drug Aricept, as the drug loses its patent protection in the UK. …
Emerging markets no haven from HTA, says NICE
February 15, 2012Andrew Witty, GSK, NICE, NICE International
The head of NICE says pharma will face health technology assessment barriers in every country – including fast-growing developing markets. …
Most patients happy with hospital care
February 15, 2012Sales and Marketing NHS, hospital, patient survey
A new survey has found that the vast majority of NHS patients receiving outpatient hospital care are happy with the …
FDA accepts Pfizer rare disease drug for review
February 15, 2012Sales and Marketing EMA, FDA, FoldRx, Pfizer, tafamidis meglumine
The FDA has accepted for review Pfizer’s new drug to treat a rare neurodegenerative disease. Pfizer is seeking a licence …
Diabetes – the battle for control
February 15, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Novo Nordisk, Sanofi, Victoza, degludec, diabetes
This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …
Strategic North appoints Paula Lashley as consultant
February 15, 2012Business Services, Medical Communications, Sales and Marketing
Healthcare strategic marketing consultancy Strategic North, who recently reached the final of the Manchester Evening News Business of the Year …
New categories for IPA Best of Health Awards
February 15, 2012Medical Communications Best of Health, IPA
This year’s IPA Best of Health Awards are now open for entries from healthcare advertising agencies worldwide. The annual awards …
Pharma critical of Obama budget
February 15, 2012Research and Development, Sales and Marketing IPAB, Independent Payment Advisory Board, Medicare, Obama, PhRMA, US, healthcare reform
President Obama has unveiled a new budget which aims to cut the US deficit by $4 trillion over the next …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
